Marygold Companies (MGLD) - Kapitalizatsiyaning sof foydaga nisbati koeffitsiyenti

Marygold Corp - MGLD emitenti grafik logotipi

Marygold Companies Inc (MGLD) diversifikatsiyalashgan holding kompaniyasi sifatida faoliyat yuritadi. Narxlar dinamikasida aks etgan bozor holati fintech sektori va oziq-ovqat ishlab chiqarishining muvaffaqiyatiga bog'liq bo'lgan moslashuvchan narxlar siyosatini namoyish etmoqda, bunda ko'rsatkich -37.80 darajasida turibdi. Marygold Companies Inc (MGLD) AQSH va rivojlangan bozorlardagi barqaror talabga tayanadi. Britaniya novvoyxonalariga nisbatan mijozlar sodiqligi sanoatdagi shiddatli raqobatga qaramay, daromadlilikni saqlab qolishga yordam beradi.

P/E multiplikatori: Marygold Companies Inc (MGLD) 21.02.2024 - 16.11.2026 uchun

The Marygold Companies, Inc. (MGLD) kompaniyasining tahliliy kesimlari

- joriy narx va aksiyalarning prognoz qilingan qiymati:
Kompaniyaning jamlanma tahlili:MGLD - The Marygold Companies, Inc.
The Marygold Companies yetakchi tovari

Barqaror aktivlarning professional tanlovi biznesning bozor qiymati va uning haqiqiy foyda keltirish qobiliyati nisbatini tahlil qilishga asoslanadi. Sof foydaga asoslangan P/E koeffitsiyentini o'rganish orqali investor Marygold Companies Inc (MGLD) kompaniyasining kapital zichligini baholaydi, bunda moliyachilarning ixcham shtati bilan yuqori boshqaruv samaradorligi xarajatlarni optimallashtirish va aksiyalarning fundamental qiymatini saqlash imkonini beradi.

Raqobatdosh kompaniyalar tahlili

Berkshire (BRK-A) - Biznesning o‘zini qoplash muddati|Narxning foydaga nisbati J&J (JNJ)|GE - Kapitalizatsiyaning foydaga nisbati|3m.com - Narx-foyda koeffitsiyenti|Illinois Tool Works Inc. - Narxning foydaga nisbati|IX: Narx-foyda koeffitsiyenti|DOV: Narxning foydaga nisbati|PAGP: P/E multiplikatori|Kanzhun Limited - Kompaniya qiymatining sof foydaga nisbati|LBRDA (Liberty Broadband) - P/E multiplikatori|SWX: Kompaniya qiymatining sof foydaga nisbati|Narxning foydaga nisbati CSW Industrials Corp (CSW)|GFF - Kapitalizatsiyaning foydaga nisbati|Otter Tail Corp - Narx-foyda koeffitsiyenti|BBUC (Brookfield Business Corp) - Kapitalizatsiyaning sof foydaga nisbati|PAM - Narxning foydaga nisbati|Kapitalizatsiyaning foydaga nisbati MDU Resources|PCH: P/E multiplikatori|CSAN - Biznesning o‘zini qoplash muddati|NWL (Newell Brands Inc) - P/E multiplikatori|Narx-foyda multiplikatori BBU (Brookfield)|P/E multiplikatori KEN|Biznesning o‘zini qoplash muddati Formula Systems (1985) Ltd.|Narxning foydaga nisbati TriMas Company TRS|ZD: Narx-foyda multiplikatori|SPB - Narxning foydaga nisbati|Biznesning o‘zini qoplash muddati Tiptree Inc. TIPT|sosyun.com (SOS) - Narxning foydaga nisbati|Narx-foyda multiplikatori RHLD|Narxning foydaga nisbati Compass Diversified Holdings|Kapitalizatsiyaning foydaga nisbati Valhi Inc VHI|Narx-foyda koeffitsiyenti TRC (Tejon Ranch)|UPXI (Upexi Corp) - Kompaniya qiymatining sof foydaga nisbati|P/E multiplikatori BBCP (Concrete Pumping Holdings, Inc.)|Kompaniya qiymatining sof foydaga nisbati PRTC|Babcock & Wilcox Enterprises, Inc. - P/E multiplikatori|NL (NL Industries) - Narx-foyda multiplikatori|Mercer International (MERC) - Narxning foydaga nisbati|Narx-foyda multiplikatori LGO|Narx-foyda koeffitsiyenti GEG|VATE: Kompaniya qiymatining sof foydaga nisbati|Narxning foydaga nisbati Star Equity (STRR)|United-Guardian (UG) - Kapitalizatsiyaning sof foydaga nisbati koeffitsiyenti|Narxning foydaga nisbati heartcore.co.jp HTCR|NXPL: Narx-foyda multiplikatori|MWYN - Narxning foydaga nisbati|Kapitalizatsiyaning sof foydaga nisbati PLAG|DSS Inc (DSS) - Narxning foydaga nisbati|Narx-foyda multiplikatori ARBB|GBR (New Concept Energy) - P/E multiplikatori|Kapitalizatsiyaning foydaga nisbati Ucommune Corp UK|P/E multiplikatori HE|Narxning foydaga nisbati AULT (Ault Alliance, Inc.)|Narxning foydaga nisbati CSW Industrials Inc CSWI|Kapitalizatsiyaning sof foydaga nisbati koeffitsiyenti Ideanomics Corp|Jewett-Cameron Trading - P/E multiplikatori|Kapitalizatsiyaning sof foydaga nisbati SPLP|VGR: P/E multiplikatori|VINO (Gaucho Group Holdings Inc.) - Narxning foydaga nisbati|Narx-foyda koeffitsiyenti RHLDV